Baidu
map

J Immunol Res:双酚A会加重过敏性鼻炎的过敏性炎症

2020-10-27 AlexYang MedSci原创

双酚A(BPA)存在于许多塑料制品中,因此是一种常见的环境内分泌干扰物。与塑料相关的健康问题,包括过敏性疾病,正引起越来越多的关注。然而,很少有研究探讨双酚A对过敏性鼻炎(AR)的影响。最近,有研究人

双酚A(BPA)存在于许多塑料制品中,因此是一种常见的环境内分泌干扰物。与塑料相关的健康问题,包括过敏性疾病,正引起越来越多的关注。然而,很少有研究探讨双酚A对过敏性鼻炎(AR)的影响。最近,有研究人员调查了双酚A是否与卵清蛋白(OVA)诱导的AR小鼠的过敏性炎症直接相关。

研究人员首先构建了OVA诱导的小鼠模型,在BPA给药后,研究人员评估了鼻腔症状,并通过ELISA检测了血清OVA特异性IgE水平。研究发现,与单纯OVA诱导的小鼠相比,添加BPA增加了鼻腔症状和血清OVA特异性IgE水平。与单独OVA暴露后相比,OVA和BPA共同暴露能够显著增加IL-4和IL-13蛋白水平。双酚A加OVA与单独暴露OVA后相比,IL-10蛋白水平趋于下降。与单独暴露于OVA后相比,OVA和BPA的共同暴露显著增加了GATA-3的mRNA水平,并降低了Foxp3和Helios的mRNA水平。与OVA单独暴露后的水平相比,BPA能够增加Th2细胞的比例,降低Tregs的比例。

BPA能够减少Tregs的比例

最后,研究人员指出,双酚A通过加剧AR过敏症状、增加血清中OVA特异性IgE水平以及损害Th2和Treg反应而产生不良作用。

原始出处:

Yunxiu Wang , Zhiwei Cao , He Zhao et al. Bisphenol A Exacerbates Allergic Inflammation in an Ovalbumin-Induced Mouse Model of Allergic Rhinitis. J Immunol Res. Sep 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-29 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 刘煜

    阅读谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 ms5000001325795111

    双酚A加重鼻炎

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2047325, encodeId=0350204e325e7, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Aug 14 17:25:17 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2059207, encodeId=082b205920efa, content=<a href='/topic/show?id=5b6d940428a' target=_blank style='color:#2F92EE;'>#过敏性炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94042, encryptionId=5b6d940428a, topicName=过敏性炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Apr 20 07:25:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350112, encodeId=7f95135011266, content=<a href='/topic/show?id=dbd33e6226c' target=_blank style='color:#2F92EE;'>#双酚A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37622, encryptionId=dbd33e6226c, topicName=双酚A)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 29 14:25:17 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894981, encodeId=ccec894981ac, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 28 06:39:47 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894980, encodeId=92f289498093, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/b08627e1c62540eeac300cd848c5e231/7259b51880ef4992bfd1285fa9f21664.jpg, createdBy=03415429647, createdName=ms5000001325795111, createdTime=Wed Oct 28 02:19:56 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894979, encodeId=4b7d8949e965, content=双酚A加重鼻炎, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb45125889, createdName=146465bem06暂无昵称, createdTime=Wed Oct 28 01:16:03 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 146465bem06暂无昵称

    双酚A加重鼻炎

    0

相关资讯

Adv Sci:低剂量双酚A潜在乳腺致癌作用的研究进展

激素水平被认为是促进乳腺癌发生的关键因素。环境内分泌干扰物(EDCs)是一类可干扰内源性激素正常功能的人工化合物。人们接触环境内分泌干扰物机会的大幅度增加被认为是导致乳腺癌发病率不断攀高的重要诱因之一。双酚A(bisphenol a, BPA)是目前产量最大、应用最广泛、研究最彻底的环境内分泌干扰物之一。动物实验和细胞实验的研究结果表明,双酚A暴露可以促进乳腺癌的发生与发展。然而,这些研究重点关注

Environ Pollut: 双酚A,甚至低水平双酚A,或对儿童都有神经毒性!

为了研究低剂量BPA是否对儿童有神经毒性,研究人员用小鼠作动物模型,将4周龄的雄性小鼠分为4组,对他们进行长达8周的不同水平的BPA处理,然后通过彗星试验和海马神经元计数检测脑细胞损伤,Y迷宫测试检测学习和记忆能力的改变,通过BPA的长期增强诱导探究其表现的潜在机制。

Semin Arthritis Rheu:血清双酚A是高尿酸血症的独立危险因素

血清BPA是高尿酸血症的独立危险因素。

Hypertension:母亲妊娠期间暴露于双酚A会对儿童血压有影响吗?

母亲妊娠期间暴露于双酚A与儿童较高的舒张压存在相关性,而且这种相关性需要在孕妇尿中双酚A浓度超出某一阈值(4.5μg/g肌酐)才存在。

Clin Endocrinol:尿双酚A水平越高,越容易肥胖!

研究数据显示,生育期的韩国女性,其肥胖、胰岛素抵抗和代谢紊乱与高尿双酚A水平有关联。 来自韩国梨花女子大学医学院的内分泌代谢内博士和同事们对296名生育期(平均年龄36岁)的健康女性进行了研究,调查内分泌干扰物质与胰岛素抵抗和肥胖之间的联系。 使用高效液相色谱-串联质谱法测定尿中双酚A(BPA)、MEHHP、MEOHP和MnBP水平。 分析结果显示,BMI (P < .01

Toxicol Sci:一些双酚A类似物的使用风险并不比双酚A低!

BPA,即双酚A,是由苯酚、丙酮在酸性介质中合成的,是环氧树脂、聚碳酸酯、聚砜、聚芳酯、酚醛树脂、不饱和聚酯树脂、阻燃剂等产品的重要原料。

Baidu
map
Baidu
map
Baidu
map